These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 17089680)

  • 21. Freeze-drying of HESylated IFNα-2b: Effect of HESylation on storage stability in comparison to PEGylation.
    Liebner R; Bergmann S; Hey T; Winter G; Besheer A
    Int J Pharm; 2015 Nov; 495(1):608-611. PubMed ID: 26387618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circumventing the heterogeneity and instability of human serum albumin-interferon-alpha2b fusion protein by altering its orientation.
    Zhao HL; Xue C; Wang Y; Li XY; Xiong XH; Yao XQ; Liu ZM
    J Biotechnol; 2007 Sep; 131(3):245-52. PubMed ID: 17698234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
    Garidel P; Pevestorf B; Bahrenburg S
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and Biological Characterization of a Prepared Recombinant Human Interferon Alpha 2b Isoform.
    Shaaban R; El-Sayed WM; Samir S; El-Dabaa E
    Appl Biochem Biotechnol; 2019 May; 188(1):72-86. PubMed ID: 30334171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability (I): stability of a monoclonal antibody.
    Abdul-Fattah AM; Truong-Le V; Yee L; Nguyen L; Kalonia DS; Cicerone MT; Pikal MJ
    J Pharm Sci; 2007 Aug; 96(8):1983-2008. PubMed ID: 17286290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a high performance size exclusion chromatography method to determine the stability of Human Serum Albumin in a lyophilized formulation of Interferon alfa-2b.
    Qian J; Tang Q; Cronin B; Markovich R; Rustum A
    J Chromatogr A; 2008 Jun; 1194(1):48-56. PubMed ID: 18258245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a lyophilization formulation that preserves the biological activity of the platelet-inducing cytokine interleukin-11 at low concentrations.
    Page C; Dawson P; Woollacott D; Thorpe R; Mire-Sluis A
    J Pharm Pharmacol; 2000 Jan; 52(1):19-26. PubMed ID: 10716599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In situ precipitation and vacuum drying of interferon alpha-2a: development of a single-step process for obtaining dry, stable protein formulation.
    Kumar V; Sharma VK; Kalonia DS
    Int J Pharm; 2009 Jan; 366(1-2):88-98. PubMed ID: 18824225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins III: collapse during storage at elevated temperatures.
    Schersch K; Betz O; Garidel P; Muehlau S; Bassarab S; Winter G
    Eur J Pharm Biopharm; 2013 Oct; 85(2):240-52. PubMed ID: 23727369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state.
    Abdul-Fattah AM; Lechuga-Ballesteros D; Kalonia DS; Pikal MJ
    J Pharm Sci; 2008 Jan; 97(1):163-84. PubMed ID: 17722086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
    Anhorn MG; Mahler HC; Langer K
    Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Freeze drying of L-arginine/sucrose-based protein formulations, part I: influence of formulation and arginine counter ion on the critical formulation temperature, product performance and protein stability.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Jul; 104(7):2345-58. PubMed ID: 25994980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of PEG crystallization in frozen and freeze-dried PEGylated recombinant human growth hormone-sucrose systems: implications on storage stability.
    Bhatnagar BS; Martin SWH; Hodge TS; Das TK; Joseph L; Teagarden DL; Shalaev EY; Suryanarayanan R
    J Pharm Sci; 2011 Aug; 100(8):3062-3075. PubMed ID: 21491456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of collapse on the stability of freeze-dried recombinant factor VIII and alpha-amylase.
    Wang DQ; Hey JM; Nail SL
    J Pharm Sci; 2004 May; 93(5):1253-63. PubMed ID: 15067701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and use of enzyme-linked immunosorbent assays (ELISA) for the detection of protein aggregates in interferon-alpha (IFN-alpha) formulations.
    Braun A; Alsenz J
    Pharm Res; 1997 Oct; 14(10):1394-400. PubMed ID: 9358552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stabilization of Octastatin, a somatostatin analogue. Preparation of freeze-dried products for parenteral injection.
    Pourrat H; Barthomeuf C; Pourrat A; Cottier PE; Ibrahim H
    Biol Pharm Bull; 1995 May; 18(5):766-71. PubMed ID: 7492997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An improved freeze-dried bilirubin preparation.
    Doumas BT; Greiff D
    Dev Biol Stand; 1976 Oct; 36():325-31. PubMed ID: 1036328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term stability of acyclovir in 0.9% NaCl infusion polyolefin bags at 5±3°C after freeze-thaw treatment: a generic product versus the brand name.
    Dewulf J; Galanti L; Godet M; Gillet P; Jamart J; Hecq JD
    Ann Pharm Fr; 2015 Mar; 73(2):108-13. PubMed ID: 25488516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation and stability of freeze-dried proteins: effects of moisture and oxygen on the stability of freeze-dried formulations of human growth hormone.
    Pikal MJ; Dellerman K; Roy ML
    Dev Biol Stand; 1992; 74():21-37; discussion 37-8. PubMed ID: 1592171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical factors affecting the storage stability of freeze-dried interleukin-1 receptor antagonist: glass transition and protein conformation.
    Chang BS; Beauvais RM; Dong A; Carpenter JF
    Arch Biochem Biophys; 1996 Jul; 331(2):249-58. PubMed ID: 8660705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.